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Liver development in mammals is initiated by the formation of a hepatic bud from the ventral foregut endoderm. The hepatic cells then
proliferate and invade the septum transversum mesenchyme, and further differentiate to give rise to hepatocytes and biliary cells. By analyzing mice
that are knockout for the transcription factors Hepatocyte Nuclear Factor-6 (HNF-6)/Onecut-1 (OC-1) and OC-2, we show here that these factors
redundantly stimulate the degradation of the basal lamina surrounding the liver bud and promote hepatoblast migration in the septum transversum.
Gene expression analysis indicates that HNF-6 and OC-2 belong to a gene network comprising E-cadherin, thrombospondin-4 and osteopontin,
which regulates liver bud expansion by controlling hepatoblast migration and adhesion. This network operating at the onset of liver development
contains candidate genes for investigation of liver carcinogenesis.
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Liver development in mice starts around embryonic day (E)
8.5 by the formation of an outgrowth of the ventral foregut
endoderm. This process is tightly controlled by interactions
between the endodermal epithelium and neighboring mesench-
ymal tissues. In particular, the cardiogenic mesoderm and the
septum transversum mesenchyme (STM) secrete Fibroblast
Growth Factors (FGF) andBoneMorphogenic Proteins (BMPs),
inducing the expression of hepatic genes in the pre-hepatic
endoderm (Bossard and Zaret, 1998; Calmont et al., 2006;
Gualdi et al., 1996; Jung et al., 1999; Rossi et al., 2001; Zaret,
1999). The expression of Secreted Frizzled Protein 5 in mouse
and Xenopus gut endoderm (Finley et al., 2003; Pilcher and
Krieg, 2002), and the role of Wnt2b in Zebrafish liver spe-⁎ Corresponding author. Fax: +32 2 7647507.
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doi:10.1016/j.ydbio.2007.09.013cification (Ober et al., 2006), suggest that Wnt signaling is also
required to initiate liver development in mammals. After hepatic
specification, hepatoblasts become columnar and proliferate to
form a liver bud. This bud, which rapidly undergoes a transition
to a pseudostratified epithelium (Bort et al., 2006), is delineated
by a laminin- and collagen IV-rich basement membrane and is
closely associated with endothelial cells. The latter promote
proliferation of the hepatoblasts via an uncharacterized me-
chanism (Matsumoto et al., 2001). By E9.5, the basement
membrane surrounding the bud is degraded, allowing the
hepatic cells to invade the surrounding STM. Further develop-
ment of the liver requires proliferation and differentiation of the
hepatoblasts, giving rise to hepatocytic cords associated with
sinusoids, and to bile ducts, which are located in the portal
spaces (reviewed in Lemaigre, 2003; Lemaigre and Zaret, 2005;
Zhao and Duncan, 2005).
Biochemical and genetic approaches have identified several
transcription factors that control the onset of liver development.
Mice deficient in Forkhead box (Fox) A1 and FoxA2 fail to
initiate liver development (Lee et al., 2005), consistent with a
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following induction by signaling from the cardiogenic meso-
derm and STM (Gualdi et al., 1996). A role for GATA trans-
cription factors in early liver development has also been
identified. Indeed, in GATA-6 null embryos hepatic specifica-
tion occurs, but the liver bud fails to expand and hepatic gene
expression is not maintained (Zhao et al., 2005). GATA-4,
whose expression is stimulated in the endoderm by signaling
from neighboring tissues (Rossi et al., 2001), most likely com-
pensates for the absence of GATA-6 in the endoderm of GATA-
6 null embryos to allow hepatic specification. In the liver bud,
GATA-4 expression abruptly decreases in hepatoblasts (Zhao et
al., 2005). The transcription factor Hematopoietically Ex-
pressed factor (Hex) is another transcription factor critical for
liver bud expansion. The endodermal cells in Hex-null embryos
proliferate at a lower rate and the hepatic bud epithelium fails to
undergo a transition from a simple columnar to a pseudostra-
tified state (Bort et al., 2004, 2006). In addition, hepatic gene
expression is not maintained, and the degradation of the basal
lamina surrounding the bud is perturbed (Bort et al., 2004; Keng
et al., 2000; Martinez Barbera et al., 2000). Like Hex, the
Prospero-related homeobox 1 (Prox1) controls early liver deve-
lopment. In Prox1-null embryos, the liver bud fails to expand,
proliferation is decreased and the basal lamina surrounding the
bud is not degraded. However, in contrast to Hex-null embryos,
Prox1-null embryos form a multilayered liver bud in which
hepatoblasts maintain liver gene expression but do not migrate
into the STM (Sosa-Pineda et al., 2000). The lack of hepatoblast
migration in the Prox1-null embryos may result in part from the
abnormally high expression of E-cadherin. Finally, the trans-
cription factor variant Hepatic Nuclear Factor (vHNF)-1 (also
called HNF-1β or Tcf2) is also reported to control liver bud
expansion, but the mechanisms involved have not yet been in-
vestigated (Haumaitre et al., 2005). Taken together, these data
indicate that a transcription factor network operating at the onset
of liver development exerts a tight control on specification,
proliferation, epithelial morphogenesis and cell migration.
The homeodomain transcription factors HNF-6 (also called
Onecut (OC)-1) and OC-2 regulate pancreas and liver deve-
lopment. Both factors are expressed in the endoderm, in the
developing pancreas, in the liver bud and, at later stages, in the
hepatocytes and biliary cells (Clotman et al., 2002; Jacquemin
et al., 2003a,b; Pierreux et al., 2004). Their role has essentially
been investigated by analyzing the phenotype of HNF-6 and
OC-2 knockout mice. They control pancreas specification,
endocrine differentiation and duct morphogenesis (Jacquemin
et al., 2000, 2003; Maestro et al., 2003; Pierreux et al., 2006;
Poll et al., 2006). In liver, HNF-6 and OC-2 control the differ-
entiation of hepatoblasts to hepatocytes or biliary cells, by
modulating the response to Transforming Growth Factor-β
(Clotman et al., 2005; Clotman and Lemaigre, 2006; Plumb-
Rudewiez et al., 2004). HNF-6 also controls hepatocyte matu-
ration as well as B-lymphopoiesis in embryonic liver (Beaudry
et al., 2006; Bouzin et al., 2003; Lannoy et al., 2002).
The expression of HNF-6 and OC-2 at the onset of liver
development suggests that these factors play a role at this stage.
To investigate this possibility, we further analyzed the phe-notype of embryos knockout for HNF-6 and OC-2. We show
here that HNF-6 and OC-2 control a gene network involved in
cell adhesion and migration and that the two factors are required
for liver bud expansion by regulating hepatoblast migration.
Methods
Animals
All mice were raised in our animal facilities and were treated according to
the principles of laboratory animal care of the local Animal Welfare Committee.
Hnf6 and Oc2 knockout mice were obtained as described (Clotman et al., 2005;
Jacquemin et al., 2000). Osteopontin knockout mice were kindly provided by D.
Denhardt, S. Rittling and A.P. Gadeau and have been described (Rittling et al.,
1998).
Detection of β-galactosidase activity
For the detection of the β-galactosidase activity, embryos were fixed at room
temperature for 15 min in a solution containing glutaraldehyde 0.4% (v/v),
MgCl2 2 mM and EGTA 5 mM in a sodium phosphate buffer (SPP) (NaHPO4
77 mM/NaH2PO4 22 mM), washed three times for 15 min in a solution con-
taining MgCl2 2 mM, Na-deoxycholate 0.01% and Nonidet P-40 0.02% in SPP,
and stained for 2–4 h at 30 °C in the washing solution containing X-gal 1mg/ml,
potassium ferricyanide 5 mM and potassium ferrocyanide 5 mM. Embryo were
then rinsed in phosphate buffer saline (PBS) and cleared in a benzyl benzoate:
benzyl-alcohol (2:1) solution. For section analysis, the stained embryos were
incubated overnight in sucrose 20% in PBS at 4 °C, embedded in PBS con-
taining sucrose 15% and gelatin 7.5%, and frozen. Transverse sections were cut
at 10 m on a cryostat.
Whole-mount detection of Prox1
For whole-mount immuno-histochemical labeling of Prox1, embryos were
fixed for 1 h at 4 °C in paraformaldehyde 4% in PBS. Endogenous peroxydase
activity was blocked by immersing the embryos in methanol containing H2O2
3% for 30 min. They were then incubated overnight with a rabbit anti-Prox-1
antibody (Covance) at 1:1000, which was detected with the Vectastain Elite
ABC kit by using DAB (Vector). After each incubation with antibodies, the
embryos were washed in TBST (Tris–Cl 50 mM, pH 7.5, NaCl 150 mM, Triton
X-100 0.1%) for 5 h with 5 changes.
Immunofluorescence and TUNEL analysis
For the immunofluorescence labeling, embryos were fixed for 2 h at 4 °C in
paraformaldehyde 4% in PBS, incubated overnight in sucrose 20% in PBS at
4 °C, embedded in PBS containing sucrose 15% and gelatin 7.5%, and frozen.
Transverse sections were cut at 10 μm on a cryostat. Primary antibodies and
dilutions were: goat anti-HNF-4α at 1:100 (Santa Cruz), rabbit anti-laminin at
1:100 (Sigma), rat anti-PECAM-1 at 1:50 (PharMingen), monoclonal mouse
anti-E-cadherin at 1:250 (BD Transduction Laboratories), rabbit anti-phospho-
histone H3 (Ser10) at 1:50 (Cell Signaling Technology), goat anti-GATA-4 at
1:250 (Santa Cruz), rabbit anti-GATA-6 at 1:50 (Santa Cruz), rabbit anti-Hex at
1:200 (kind gift from C. Bogue) and rabbit anti-Prox1 at 1:500 (Covance).
Secondary antibodies and dilutions were donkey anti-goat/AlexaFluor 594 at
1:2000, anti-rabbit/AlexaFluor 594 at 1:3000 or anti-rat/AlexaFluor 594 at
1:1000 (Invitrogen), or biotinylated sheep anti-rabbit and anti-mouse antibody at
1:250 (Chemicon) followed by streptavidin-AlexaFluor 488 at 1:2000
(Invitrogen).
The TUNEL assay was performed by using the Fluorescein in situ Cell
Death Detection kit from Roche. The manufacturer’s protocol was modified to
allow co-labeling with the anti-Prox1 and the anti-GATA4 antibodies. Briefly,
sections were unmasked by boiling in sodium citrate buffer 0.1 M, pH 6.0, for
5 min, permeabilized on ice in sodium citrate 0.1%, Triton X-100 0.1% for 2 min
and incubated for 1 h at 37 °C with the TUNEL mix. Then, sections were
blocked in a solution containing bovine serum albumin 5%, non fat dry milk 3%,
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described above. Fluorescence was detected with a Zeiss Axiovert 200 inverted
fluorescence microscope. All pictures were taken using a Coolpix 995 digital
camera (Nikon). Quantification of proliferation was done by counting phos-
phohistone-H3, GATA-4 and HNF-4α positive nuclei.
DNA array analysis
DNA array analyses were performed using an oligo GEArray Mouse Extra-
cellular Matrix and Adhesion Molecules microarray (OMM-013, SuperArray).
Total RNA was used as template to synthesize biotinylated cRNA, using the
TrueLabeling-AMP Linear RNA Amplification Kit (SuperArray). The cRNA
was hybridized overnight at 60 °C with oligo arrays. After washing, arrays were
dried and analysed with the Chemiluminescent Detection Kit (SuperArray),
according to the manufacturer’s instructions. Images were quantified using the
data analysis software (GEArray Analyzer).
Reverse-transcriptase polymerase chain reaction (RT-PCR) and
real-time quantitative RT-PCR
Total RNA was extracted from embryonic liver with the Tripure Isolation
Reagent (Roche) and was incubated for 10 min at room temperature and for 2 h
at 37 °C in a volume of 25 μl containing Tris–Cl 50 mM (pH 8.3), KCl 5 mM,
MgCl2 3 mM, dithiothreitol 10 mM, 200 units of Moloney Murine Leukemia
Virus reverse transcriptase (Life Technologies), 40 units of Rnase OUT (Pro-
mega), 3 μg of random hexamers (Life Technologies) and dNTPs 4 mM
(Amersham Pharmacia Biotech).
Real-time PCR was performed with SYBR Green Master Mix Reagent (In-
vitrogen) on a MyiQ cycler (Bio-Rad). Threshold cycles were transformed into
copy number according to the standard calibration curve. Absolute copy number
for each mRNAwas normalized to β-actin or Prox1mRNA copy number. Primer
sequences were 5′-TCCTGAGCGCAAGTACTCTGT-3′ and 5′-CTGATCCA-
CATCTGCTGGAAG-3′ for β-actin, 5′-CCGACATCTCACCTTATTGAG-3′
and 5′-TGCGAGGTAATGCATCTGTTG-3′ for Prox1, 5′-AGGGAGCTGTC-
TACCAAAGTG-3′ and 5′-CCAGTCTCGTTTCTGTCTTC-3′ for E-cadherin,
5′-GAAAGCAACGGGAGATCCTC-3′ and 5′-GACTGCCCAGGCCCCTGG-
TTCTGT-3′ for HNF-1β, 5′-TCTGTCAGCCGTGTTTGAGC-3′ and 5′-
ATCTGCCCCAGAAGAGGAG-3′ for vitronectin, 5′-GACCGCTTGTAATT-
GAGC-3′ and 5′-TTGACGTATTTGGGCTGGTA-3′ for thrombospondin-4, 5′-
TGAGATTGGCAGTGATTTGC-3′ and 5′-CTGCTTCTGAGATGGGTCAG-
3′ for osteopontin, 5′-CTGAGGGGAATGAAGACCAG-3′ and 5′-TCCAGTT-
CTTGGGCAGTTGG-3′ for bone sialoprotein, 5′-CCACGAACAGTGAGT-
CATC-3′ and 5′-TCGCCAAAGGTATCATCTCC-3′ for Dentin matrix protein,
5′-AGCCTTCAATGTGGAACGAG-3′ and 5′-CCACCGCTTCATAGGT-
CATC-3′ for Hyaluronan Synthase-1 (HAS-1) and 5′-GCCTCATCTGTGGA-
GATGG and 5′-TCCCAGAGGACCGCTTATGC-3′ for HAS-2.
Results
HNF-6 and OC-2 control early liver expansion
To investigate a possible role of HNF-6 and OC-2 in early
liver development, we analyzed the phenotype of mice knock-
out for HNF-6 and/or OC-2. These mice have been described
earlier (Clotman et al., 2005; Jacquemin et al., 2000) and were
obtained by introducing a neomycine-resistance cassette in the
first exon of the Hnf6 gene (Hnf6−/−) and by inserting β-galac-
tosidase coding sequences in-frame into the first exon of the
Oc2 gene (Oc2lacZ/lacZ).
OC-2 is expressed in the hepatic epithelial cells throughout
liver development, starting in the endoderm. Since β-galacto-
sidase activity mimics OC-2 expression (Clotman et al., 2005),
liver morphology can be assessed by β-galactosidase staining of
embryos that have an allele with a lacZ knockin. Inactivation ofone Oc2 allele (Hnf6+/+;Oc2+/lacZ) did not perturb the expected
normal morphology at E10.5 (Fig. 1A). The inactivation of two
alleles of Oc2, even in association with one inactivated allele of
Hnf6 (Hnf6+/−;Oc2lacZ/lacZ), did not produce significant
changes in liver morphology (Fig. 1B), indicating that the
lack of OC-2 alone does not impact on early liver expansion. In
contrast, when embryos had a homozygous inactivation of the
Hnf6 gene combined with inactivation of one or two alleles of
Oc2 (Hnf6−/−;Oc2+/lacZ and Hnf6−/−;Oc2lacZ/lacZ embryos),
the liver was strongly hypoplastic (Figs. 1C, D). The morpho-
logy of livers that lack HNF-6 expression (Hnf6−/−;Oc2+/+)
was visualized by whole mount staining with a Prox1 antibody
at E10.5. The results showed only a minor reduction in liver size
in the absence of HNF-6 as compared to controls (Figs. 1L–N).
Since the phenotypes of Hnf6−/−;Oc2+/lacZ and Hnf6−/−;
Oc2lacZ/lacZ embryos were indistinguishable, they are hereafter
called Hnf6/Oc2-deficient embryos, and wild-type or Hnf6+/+;
Oc2+/lacZ embryos were used as controls.
To determine at which developmental stage liver expansion
becomes impaired in the Hnf6/Oc2-deficient embryos, we
analyzed earlier stages of development. At E9.5 these embryos
showed a hypoplastic and less irregular liver bud as compared
to the control embryos (Figs. 1E–H). However, slightly earlier,
at E9, no evidence of liver hypoplasia was found (Figs. 1I–K),
suggesting that impaired liver expansion starts between E9 and
E9.5.
From this set of experiments, we concluded that HNF-6 and
OC-2 exert a redundant activity on early liver expansion.
HNF-6 and OC-2 control early hepatoblast migration
To determine how HNF-6 and OC-2 control early liver deve-
lopment, we first envisaged the possibility that liver hypoplasia
in Hnf6/Oc2-deficient embryos resulted from abnormal hepatic
differentiation. At E9 (18–21 somites), Hnf6/Oc2-deficient
hepatoblasts expressed Hex, Prox1, GATA-6 and HNF-4α (Figs.
2A–H), as in controls. In addition, in control and Hnf6/Oc2-
deficient embryos, the septum transversum expressed GATA-6
and GATA-4, and GATA-4 was absent from the hepatoblasts
(Figs. 2C, D and I, J). Moreover, the expression of HNF-1β
which was measured by quantitative RT-PCR, was normal in the
mutant embryos (Fig. 5A). Therefore, we found no evidence for
abnormal differentiation in Hnf6/Oc2-deficient embryos.
Liver hypoplasia in these embryos might also result from
reduced proliferation of the hepatoblasts or of the STM. This
was measured by double immunofluorescent staining of liver
buds with antibodies against the hepatoblast marker HNF-4α or
the STM marker GATA-4, and the proliferation marker phos-
phohistone H3 (Figs. 2O–R). At E9.5, the percentage of pro-
liferating hepatoblasts was 17.8±2.7% (mean±SEM, n=6) in
control embryos, and 11.9±2.3% (mean±SEM, n=7) in Hnf6/
Oc2-deficient embryos. However, this difference was not stat-
istically significant (p value=0.12, Student’s t test). Also, the
percentage of proliferating STM cells was 14.6±1.5 (mean±
SEM, n=3) in control embryos, and 11.3±0.9 (mean±SEM,
n=3) in Hnf6/Oc2-deficient embryos. Again, this difference
was not statistically significant (p value=0.13, Student’s t test).
Fig. 1. HNF-6 and OC-2 control early liver expansion. (A–K) Liver morphology from E9 to E10.5 is assessed by staining for β-galactosidase activity in embryos in
which at least one Oc2 allele contains an in-frame knockin of the LacZ gene. (A–D) At E10.5, inactivation of two alleles of Oc2 in association with one inactivated
allele of Hnf6 does not induce significant changes in liver morphology as compared to control embryos, whereas homozygous inactivation of the Hnf6 gene combined
with inactivation of one or two alleles of Oc2 induces liver hypoplasia. (E–H) At E9.5, Hnf6/Oc2-deficient embryos show liver hypoplasia. (I–K) At E9.0, no
evidence for liver hypoplasia is found, suggesting that impaired liver growth starts between E9 and E9.5. (L–N) At E10.5, whole-mount Prox1 labeling shows minor
reduction in liver size in the absence of HNF-6 as compared to controls. l: liver bud, dp: dorsal pancreatic bud. The dotted lines surround the liver. Scale bars, 250 μm.
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(Matsumoto et al., 2001). Therefore, we verified if these cells
were present in Hnf6/Oc2-deficient embryos by performing
PECAM staining on liver bud sections. The results showed that
at E9 (18–21 somites), endothelial cells were found in Hnf6/
Oc2-deficient embryos as in controls (Figs. 2E, F).
Another possible cause of liver hypoplasia in Hnf6/Oc2-
deficient embryos is apoptosis. This possibility was addressed
by performing TUNEL assays on sections co-stained for the
hepatoblast marker Prox1 or for the STM marker GATA-4. No
significant apoptosis was detected on sections from control or
Hnf6/Oc2-deficient embryos (Figs. 2K–N). Other regions of
the embryo served as positive control for the TUNEL assay
(data not shown).Given the regular shape of liver buds in Hnf6/Oc2-deficient
embryos as compared to control embryos at E9.5 (Figs. 1E–H),
we hypothesized that HNF-6 and OC-2 control hepatoblast
migration. We sectioned embryos that had been stained for β-
galactosidase activity at E9.5 (25–26 somites) and analyzed the
morphology of the liver bud. It appeared multilayered and
pseudostratified in all embryos, but delamination of the hepa-
toblasts and invasion of the STM was impaired in Hnf6/Oc2-
deficient embryos (Figs. 3A–C). Defective delamination was
transient, since at later stages the hepatoblasts have invaded the
STM and have colonized the liver lobes (Figs. 4M, N). The lack
of liver bud expansion in Hnf6/Oc2-deficient embryos is
reminiscent of the phenotype of Prox1-null embryos, in which
hepatoblasts do not migrate into the STM, possibly as a result
Fig. 2. HNF-6 and OC-2 are not involved in early liver differentiation, apoptosis, proliferation, or in the maintenance of endothelial cells around the liver bud. (A–J)
Immunofluorescence analyses were performed on transverse sections of Hnf6+/+;Oc2+/LacZ and Hnf6−/−;Oc2+/LacZ liver buds at E9 (18–21 Somites). The expression
of the early hepatic markers Hex, GATA-6, Prox1, HNF-4α and GATA-4 is not affected in the absence of HNF-6 and OC-2. (E, F) Endothelial cells are present around
the liver bud of control and Hnf6/Oc2-deficient embryos, as detected by PECAM staining. (K–N) The liver hypoplasia in Hnf6/Oc2-deficient embryos is not due to
apoptosis of hepatoblasts or STM cells. TUNEL assay was performed in parallel with immunofluorescent detection of Prox1 in order to delineate the liver bud or of
GATA-4 to label the STM. (O–R) Proliferation is not perturbed in the absence of HNF-6 and OC-2. Phosphohistone H3 positive cells were co-detected with HNF-4α
or GATA-4 to label the hepatoblasts and the STM, respectively. The dotted lines delineate the liver bud and migrating hepatoblasts. Scale bars, 50 μm.
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Fig. 3. HNF-6 and OC-2 control hepatoblast migration and basement membrane degradation. (A–C) E9.5− embryos (25–26 somites) were stained for β-galactosidase
activity and sectioned. The hepatoblasts of control andHnf6+/-;Oc2LacZ/LacZ embryos migrate out of the liver bud and invade the septum transversum mesenchyme. By
contrast, hepatoblasts of Hnf6/Oc2-deficient embryos fail to migrate into the surrounding mesenchyme. (D–I) The degradation of the basal lamina is delayed in Hnf6/
Oc2-deficient embryos. At E9.0, the hepatoblasts, which express HNF-4α, are surrounded by a laminin layer that is already partially degraded in control embryos but
not yet in Hnf6/Oc2-deficient embryos. At A9.5 (26–27 somites), the laminin layer is degraded in all embryos, but the number of Hnf6/Oc2–deficient hepatoblasts
that have invaded the STM is reduced as compared to controls. Panels D–I show laminin and HNF-4α staining, panels D'–I' only show the laminin staining. Scale
bars, 50 μm.
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liver bud (Sosa-Pineda et al., 2000). As mentioned above, Hnf6/
Oc2-deficient embryos have normal expression of Prox1 (Figs.
2E, F, K, L and 5B). However, in these embryos, the degra-
dation of the basal membrane surrounding the liver bud is
slightly delayed. Indeed, in Hnf6/Oc2-deficient embryos at E9(20 somites), the liver bud is surrounded by a continuous layer
of laminin, whereas the latter is already degraded in controls
(Figs. 3D–F and D’–F’). At E9.5 (26–27 somites), the laminin
layer is degraded in all embryos, but the number of Hnf6/Oc2-
deficient hepatoblasts that have invaded the STM is reduced as
compared to controls (Figs. 3G–I). In Prox1-null embryos, the
Fig. 4. HNF-6 and OC-2 control E-cadherin expression in early liver development. (A–F) Transverse sections ofHnf6+/+;Oc2+/LacZ andHnf6−/−;Oc2+/LacZ embryos at
E9.5 show that the hepatoblasts, which remain associated with the liver bud, express normal levels of E-cadherin. Embryos were co-stainedwith a Hex antibody to allow
detection of the liver bud. Panels E and F are higher magnification pictures of the boxed area in panels C and D. (G–N) At E11.5, the Hnf6−/−;Oc2+/LacZ hepatoblasts
colonize the liver lobes, but form clusters that are surrounded by laminin and show higher E-cadherin levels than in controls. HNF-4α detection is used to identify the
hepatoblasts. The dotted lines surround the liver. Panels M and N are lowmagnification views to illustrate the colonization of liver lobes by the hepatoblasts. Scale bars,
50 μm.
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sion of E-cadherin (Sosa-Pineda et al., 2000). In Hnf6/Oc2-
deficient embryos at E9.5 hepatoblasts remained associated
with the liver bud but expressed normal levels of E-cadherin
(Figs. 4A–F and 5C). In contrast, at E11.5, they had invaded the
STM, but formed clusters that expressed higher levels of E-
cadherin than in controls (Figs. 4G–L) and which were sur-
rounded by laminin. This was confirmed by quantitative RT-
PCR experiments in which the concentration of E-cadherin
mRNA, normalized for Prox1 mRNA, was significatively in-
creased in Hnf6/Oc2-deficient embryos (Fig. 5D).
Taken together, the data suggest that HNF-6 and OC-2 are
not involved in early differentiation, proliferation or apoptosis,but that they control hepatoblast migration, E-cadherin expres-
sion and degradation of the basement membrane at the onset of
liver development.
HNF-6 and OC-2 control the expression of genes involved in
cell migration and adhesion
To further investigate the mechanism by which HNF-6 and
OC-2 control early liver expansion, we analyzed the expression
of genes that relate to extracellular matrix biology and cell
adhesion. We resorted to an array approach allowing to test the
expression of 113 genes (oligo GEArray; see Methods). The
analysis was performed to compare the RNA of pooled control
586 S. Margagliotti et al. / Developmental Biology 311 (2007) 579–589(n=3) and Hnf6−/−;Oc2+/lacZ (n=4) liver buds microdissected
at E9 (21 somites). Each gene was spotted in quadruplicate on
the GE array. The results are shown in Table 1.
Among the matrix degrading enzymes, detectable expression
was found for matrix-metalloprotease (MMP)-2 and -14. In
Hnf6/Oc2-deficient embryos, their expression, as well as that of
basal lamina components, was normal. These data suggested that
delayed degradation of the basement membrane in Hnf6/Oc2-
deficient embryos does not result from overproduction of itsconstituents or from deficient expression of matrix-degrading
enzymes.
A number of proteins are involved in the control of cell
adhesion and migration. As shown in Table 1, Thrombospon-
din-4 (Thbs4) was upregulated in Hnf6/Oc2-deficient embryos.
This was confirmed by quantitative RT-PCR (2.6-fold increase,
Fig. 5E). Thbs4 is a glycoprotein of the extracellular matrix with
unknown function in the liver. However, it enhances the ability
of laminins to promote adhesion and neurite outgrowth of
embryonic retinal cells (Arber and Caroni, 1995; Dunkle et al.,
2007), raising the possibility that an excess of Thbs4 decreases
hepatoblast migration.
Interestingly, the array experiments also indicated that the
expression of osteopontin (OPN), also called secreted phos-
phoprotein-1 (Spp1) or early T-cell activation-1 (ETA-1), was
downregulated in Hnf6/Oc2-deficient embryos. Quantitative
RT-PCR experiments confirmed the array data and showed that
OPN expression is decreased 47-fold at E9.0 (Fig. 5F). This
reduction is stronger than that measured with the GEArray data,
because the OPN mRNA levels in Hnf6/Oc2-deficient embryos
had reached the background for detection on the array. OPN is a
secreted protein of the small integrin-binding ligand N-linked
glycoprotein (SIBLING) family, to which a wide range of
biological functions have been ascribed (reviewed in Denhardt
et al., 2001; Mazzali et al., 2002, Rangaswami et al., 2006). It
binds to several receptors including integrins and variants of the
hyaluronan receptor CD44. Most relevant to the present work is
its proposed role in promoting scattering and migration of
cultured embryonic hepatic cells (Medico et al., 2001),
suggesting that decreased expression of OPN in Hnf6/Oc2-
deficient embryos contributes to impaired hepatoblast migra-
tion. Therefore, we analyzed OPN knockout embryos (Rittling
et al., 1998), but found no evidence for defective hepatoblast
migration during early liver development (data not shown).
A number of proteins are considered to have potentially
redundant roles with OPN. These include other members of the
SIBLING family such as bone sialoprotein (Bsp) and dentin
matrix protein (Dmp) (Fisher et al., 2001; Wilson et al., 2005),
or ligands, such as vitronectin and hyaluronan that, like OPN,
bind to integrin αVβ3 and to CD44, respectively. We measuredFig. 5. HNF-6 and OC-2 control the expression of genes in early liver deve-
lopment. Total RNAwas extracted from livers at E9.5 or E11.5 and expression of
genes was measured by quantitative RT-PCR. Grey bars represent control livers
and open bars represent mutant livers. (A–C) The expression of HNF-1β, Prox1
and E-cadherin is normal in the absence of HNF-6 and OC-2 at E9.5 (control:
n=7; Hnf6/Oc2-deficient: n=5). (D) At E11.5, the expression of E-cadherin is
significantly increased in Hnf6/Oc2-deficient hepatoblasts. (*p=0.015; control:
n=4;Hnf6/Oc2-deficient: n=6). (E, F) At E9, the expression of thrombospondin
4 is 2.6-fold increased whereas those of osteopontin is 47-fold decreased in
Hnf6−/−;Oc2+/LacZ liver buds, confirming theGE array analysis. The analysis was
performed on pooled control (n=3) or Hnf6−/−;Oc2+/LacZ (n=4) liver buds. (G)
At E9.5, the expression of bone sialoprotein is normal in Hnf6/Oc2-deficient
and in OPN knockout livers (controls: n=3; Hnf6/Oc2-deficient n=4; OPN
knockout: n=3). (H) The expression of vitronectin at E9.5 is normal in Hnf6/
Oc2-deficient liver (control: n=3; Hnf6/Oc2-deficient n=4), but is significantly
increased in OPN knockout embryos (**p=0.006; control: n=3; OPN
knockout; n=3). Given that Hnf6/Oc2-deficient and OPN knockout embryos
are not in the same genetic background, the data on the two strains, named HNF-
6/OC-2 and OPN strains, are shown separately in panels G and H.
Table 1
RNA from pooled control livers (n=3) was compared with that from Hnf6−/−;
Oc2+/lacZ (n=4) livers microdissected at E9 (21 somites)
Symbol Control Hnf6−/−;
Oc2+/lacZ
Fold
increase
Gene
Thrombospondin 4 Thbs4 7624 23,214 3.0
Vitronectin Vtn 18,441 27,257 1.5
Thrombospondin 3 Thbs3 16,687 21,196 1.3
Tissue inhibitor of
metalloproteinase 2
Timp2 17,700 20,831 1.2
Tissue inhibitor of
metalloproteinase 3
Timp3 18,275 19,290 1.1
Catenin beta Catnb 53,074 53,480 1.0
Catenin alpha 1 Catna1 52,440 51,331 1.0
Fibronectin 1 Fn1 51,998 49,475 1.0
Elastin microfibril interfacer 1 Emilin1 37,642 35,624 0.9
Fibulin 1 Fbln1 36,908 34,636 0.9
Secreted acidic cysteine rich
glycoprotein
Sparc 48,677 45,344 0.9
Procollagen, type VI, alpha 1 Col6a1 32,985 30,189 0.9
Procollagen, type VI, alpha 2 Col6a2 26,193 23,954 0.9
Laminin B1 subunit 1 Lamb1-1 52,070 46,867 0.9
Procollagen, type IV, alpha 3 Col4a3 28,126 25,266 0.9
Procollagen, type XVIII, alpha 1 Col18a1 46,726 40,135 0.9
Periostin, osteoblast specific factor Postn 50,652 43,342 0.9
Procollagen, type V, alpha 1 Col5a1 45,098 37,612 0.8
Cadherin 2 Cdh2 41,985 34,619 0.8
Sarcoglycan, epsilon Sgce 39,933 32,729 0.8
Chondroitin sulfate proteoglycan 2 Cspg2 42,753 34,620 0.8
Procollagen, type IV, alpha 6 Col4a6 29,228 23,485 0.8
Extracellular matrix protein 1 Ecm1 41,690 32,909 0.8
Integrin beta 1 (fibronectin
receptor beta)
Itgb1 44,179 34,699 0.8
Procollagen, type I, alpha 1 Col1a1 37,537 29,472 0.8
Procollagen, type III, alpha 1 Col3a1 43,141 33,300 0.8
Procollagen, type IV, alpha 2 Col4a2 36,761 28,225 0.8
Procollagen, type IV, alpha 1 Col4a1 42,935 32,740 0.8
Matrix metalloproteinase 2 Mmp2 47,575 36,258 0.8
Matrix metalloproteinase 14 Mmp14 49,341 36,719 0.7
Connective tissue growth factor Ctgf 37,992 27,809 0.7
A disintegrin-like metalloprotease
with thrombospondin 1 motif, 2
Adamts2 29,971 21,679 0.7
Transforming growth factor,
beta induced
Tgfbi 45,425 32,303 0.7
Hyaluronan and proteoglycan
link protein 1
Hapln1 29,207 20,530 0.7
Secreted phosphoprotein 1
(osteopontin)
Spp1 38,386 14,135 0.4
House keeping gene
Beta-2 microglobulin B2m 32,593 40,831 1.3
Heat shock protein 1, beta Hspcb 53,347 53,949 1.0
Peptidylprolyl isomerase A Ppia 54,917 54,842 1.0
Heat shock protein 1, beta Hspcb 54,226 54,134 1.0
Peptidylprolyl isomerase A Ppia 55,302 54,755 1.0
Ribosomal protein S27a Rps27a 53,246 52,680 1.0
Biotinylated Artificial Sequence 2 BAS2C 55,187 54,378 1.0
Biotinylated Artificial Sequence 2 BAS2C 54,911 51,399 0.9
Each gene was spotted in quadruplicate on the GE array. Values correspond to
arbitrary densitometric units provided by the GEArray Analyzer software.
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synthases (HAS)-1 and -2 by quantitative RT-PCR in control,
Hnf6/Oc2-deficient and in OPN knockout livers. We found no
detectable expression of Dmp and of HAS-1 and HAS-2, and nosignificant difference in the levels of Bsp (Fig. 5G). Vitronectin
was overexpressed in the livers of OPN knockout mice (Fig.
5H), indicating that the absence of OPN induces potentially
compensatory mechanisms. However in Hnf6/Oc2-deficient
embryos, we detected no significant change in vitronectin ex-
pression as compared to controls (Fig. 5H).
In conclusion, the morphological analysis and the gene ex-
pression profile of livers deficient in HNF-6 and OC-2 show
that these two factors control the expression of a network of
genes comprising Thbs4, OPN and E-cadherin, that are in-
volved in cell adhesion and migration, and whose deregulation
during early liver development is associated with impaired
hepatoblast migration and enhanced cell clustering.
Discussion
In the present paper, we investigated the role of the Onecut
transcription factors HNF-6 and OC-2 in early liver develop-
ment and found that they exert a redundant control on early liver
expansion. The absence of both factors in knockout mice is
associated with delayed degradation of the basement membrane
surrounding the liver bud, impaired hepatoblast migration into
the STM, increased hepatoblast clustering, and perturbed ex-
pression of a network of genes involved in cell adhesion and
migration.
Perturbed degradation of the basal lamina surrounding the
liver bud, and impaired migration of hepatoblasts are charac-
teristics of Hnf6/Oc2-deficient embryos, but are also hallmarks
of embryos deficient in the transcription factor Prox1 (Sosa-
Pineda et al., 2000). This suggests that HNF-6, OC-2 and Prox1
are involved in a common gene regulatory network controlling
specific aspects of early liver development. While the expres-
sion of Prox1 is unaffected in Hnf6/Oc2-deficient embryos, it is
unknown if HNF-6 and/or OC-2 are regulated by Prox1. The
fact that HNF-6, OC-2 and Prox1 may belong to common gene
regulatory networks is further underscored by the observation
that the pancreatic phenotypes of Prox1-null and HNF-6-null
embryos bear significant similarities: both knockout embryos
show hypoplastic pancreas and impaired development of
endocrine progenitors starting around e12.5 (Jacquemin et al.,
2000, 2003; Wang et al., 2005). Furthermore, Prox1 stimulates
OPN expression in the pancreas (Wang et al., 2005), as do HNF-
6 and OC-2 in the liver.
In Hnf6/Oc2-deficient embryos, we detected a delay in the
degradation of the basement membrane surrounding the liver
bud. Gene expression analysis using oligoGEArrays failed to
provide evidence for abnormal expression of basement mem-
brane components or of extracellular matrix-degrading en-
zymes. However, our data cannot rule out the possibility that
HNF-6 and OC-2 indirectly control the post-translational
regulation of MMP activity.
Hnf6/Oc2-deficient embryos showed reduced migration of
the hepatoblasts from the liver bud into the STM and our ana-
lysis demonstrated that HNF-6 and OC-2 control the expression
of OPN, Thbs4 and E-cadherin, which are involved in cell
migration and adhesion. OPN was downregulated in Hnf6/Oc2-
deficient embryos. It belongs to the SIBLING family of matri-
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motes cell migration and cancer invasiveness (reviewed in
Denhardt et al., 2001; Mazzali et al., 2002, Rangaswami et al.,
2006). In vitro, OPN promotes scattering and migration of em-
bryonic liver cells (Medico et al., 2001). Downregulation of
OPN may contribute to the decreased hepatoblast migration in
Hnf6/Oc2-deficient embryos, but it is not sufficient given that
OPN knockout mice have normal hepatoblast migration. Vitro-
nectin, which, like OPN, binds to integrin αVβ3, is a good
candidate to exert redundant functions with OPN. Interestingly,
vitronectin expression was upregulated in OPN knockout em-
bryos, suggesting that it may compensate for the absence of
OPN and allow normal hepatic development in these embryos.
By contrast, there was no vitronectin upregulation in Hnf6/Oc2-
deficient embryos and we suggest that this may result in the
absence of compensation, leading to a deficient hepatoblast
migration. Little information is available about the function of
Thbs4. Thrombospondins are matricellular proteins that pro-
mote disruption of focal adhesions and reorganization of actin
stress fibbers, thereby enabling cellular migration (Borstein and
Sage, 2002). Thbs4 is known to promote adhesion of embryonic
retinal cells to extracellular matrix proteins (Dunkle et al.,
2007), raising the possibility that it modulates hepatoblast cell
migration. The regulation of the E-cadherin expression is com-
plex and is notably important for the modulation of the mig-
ration of different type of cells. Indeed, the repression of E-
cadherin decreases cell–cell interactions and thereby favors the
migration of epithelial type cells. The upregulation of E-
cadherin might contribute to the impaired hepatoblast migration
and increased cell clustering at the onset of liver development,
as seen in Hnf6/Oc2-deficient embryos. Collectively, our data
suggest that HNF-6 and OC-2 fine-tune a network of genes
involved in cell adhesion and migration, and that the unbal-
anced expression of those genes in the absence of Onecut fac-
tors leads to impaired migration and enhanced cell clustering.
Our data do not imply that HNF-6 and OC-2 exert a direct
regulation of the genes, which are up- or downregulated in
Hnf6/Oc2-deficient embryos. However, Odom et al. (2007)
identified E-cadherin and vitronectin as direct targets of HNF-6
in adult hepatocytes, suggesting that at least part of the network
of genes regulating cell adhesion and migration is directly con-
trolled by the Onecut factors.
Expression of a number of cell adhesion molecules, includ-
ing E-cadherin, is co-ordinately stimulated by HNF-4α (Battle
et al., 2006), and our results, together with those of Sosa-Pineda
and colleagues (2000), show that HNF-6, OC-2 and Prox1 co-
ordinately repress E-cadherin expression. Although the control
exerted on E-cadherin by HNF-4α is described at later stages of
liver development than its regulation by HNF-6, OC-2 and
Prox1, these data collectively suggest that hepatic cell adhesion
during development relies on a balance of the effect of all four
transcription factors. Cancer invasiveness and metastasis form-
ation are associated with loss of cell–cell interaction, E-cadhe-
rin repression, basement membrane degradation and increased
cell motility. Also, OPN, which we show here to be a target of
HNF-6 and OC-2, is a marker of hepatocarcinoma and promotes
angiogenesis, tumor invasion, migration and metastatic spread(Denhardt et al., 2001; Mazzali et al., 2002; Rangaswani et al.,
2006). Therefore, our findings in developing liver raise the
possibility that a network comprising HNF-6, OC-2, Prox1 and
HNF-4α plays a role in hepatic cancer.
In conclusion, the present work uncovers the role of a gene
network operating at the onset of liver development to control
liver bud expansion, and provides candidate genes for invest-
igation of liver carcinogenesis.
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